Jaws Acquisition Corp.

Status: Deal Closed
U=S+W/3 W=S@11.5
IPO Proceeds, $M $690.00M
IPO Date May 14, 2020
CEO Joseph L. Dowling
Left Lead Credit Suisse
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector General

Growth-oriented companies

IPO Geography Global
Target Company Cano Health
Deal Announced Nov 12, 2020
Deal Size, $M $4,400.00M
Deal Sector Healthcare
Deal Geography US/Canada
SEC Filings www.sec.gov
Approval Vote Jun 2, 2021
Amendment Vote TBD
Closing Date Jun 3, 2021
Formerly JWS CANO CANO/W

Sign up for Free Trial

No credit card required

Sign in for more on Jaws Acquisition Corp.:

  • Structure and cap table
  • 6 directors & officers
  • 28 filings and events
  • 3 underwriters
  • 3 deal advisors
  • 3 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Barry S. Sternlicht 59 Chairman
Joseph L. Dowling 55 Chief Executive Officer
Michael Racich 48 Chief Financial Officer
Douglas I. Ostrover 57 Director
Michael Baldock 56 Director
Benjamin Weprin 41 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Credit Suisse Joint BR 40,200,000 units
Morgan Stanley Joint BR 9,900,000
Citigroup Joint BR 9,900,000
60,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 28 filings.

Shareholders

Sign in to view shareholders 13F filing data.